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Distal Axonopathy: One Common Type
of Neurotoxic Lesion
by Peter S. Spencer* and Herbert H. Schaumburg*
Neurotoxic chemicals commonly produce retrograde degeneration ofthe axons oflong and large nerve
fibers in the central and peripheral nervous system. This produces a clinical picture of polyneuropathy
in man and animals in which sensory and motor disturbances develop in the feet and hands then pro-
gress with time to the legs and arms. Distal axonopathy, as the underlying pathologic process is termed,
is one of four principal types of neurotoxic diseases, the others including degeneration of neurons
(neuronopathy), myelin sheaths (myelinopathy) and damage to the neurovasculature (neurovas-
culopathy). In the experimental animal, these four types of neurotoxic diseases can be distinguished by
examining selected areas of brain and nerve tissues prepared by contemporary methods of tissue rixa-
tion. These procedures may form the basis of a new and sensitive assay for neurotoxicity.
The word "neurotoxin" conveys a variety of
meanings. To the behaviorist, neurotoxins produce
abnormal patterns of behavior; to the physiologist,
a discrete functional impairment; to the phar-
macologist, a metabolic alteration; to the
neurologist, a clinical syndrome, and to the
neuropathologist and neurochemist respectively,
structural and biochemical alterations ofthe central
or peripheral nervous systems. Part of this confu-
sion arises from the practice of using the word
neurotoxin to describe compounds with widely dif-
fering pathophysiological actions. For example, the
term includes the biological neurotoxins such as
venoms, curare, tetanus, and diphtheria toxins,
pharmacological agents such as tranquilizers, nar-
cotics, anesthetics, stimulants, antidepressants,
hallucinogens and antimicrobials, and environ-
mental pollutants such as heavy metals, pesticides,
solvents, and a variety ofother industrial chemicals
(1).
There is a paucity of information on the
neurotoxic effects ofmost compounds, and this lack
of data prevents the development of a systemic
classification of neurotoxins. However, in general,
it is important to distinguish between the acute,
pharmacological and frequently reversible nervous
system effects ofa chemical or drug, and the struc-
tural, often irreversible damage more commonly as-
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sociated with chronic exposure to a compound.
This paper is concerned with the morphological as-
pects of neurotoxicity.
Establishing Normative Data
The examination of the structure and pathology
ofthe nervous system is difficult because oftechni-
cal problems relating to tissue preparation. Con-
ventional methods of tissue analysis which utilize
light microscope examination of sections of
formaldehyde-fixed, paraffin-embedded autopsy
and biopsy material are unsatisfactory for the as-
sessment of neurotoxicity. The problem lies not in
the use ofthe light microscope, but in the poor tis-
sue preservation inherent with the conventional
technique. Since there is poor structural resolution,
it is impossible to achieve a sensitive morphological
assay of neurotoxicity. Morphological techniques
which overcome these problems and are within the
scope of most histology laboratories, have been
available for 20 years and are routinely used in
academic research. These contemporary techniques
employ perfusion fixation with buffered glutaral-
dehyde, post-fixation in osmium tetroxide, thin
plastic sections, and general purpose stains (2). Al-
though originally developed for use in conjunction
with electron microscopy, such methods also pro-
vide optimal preparations of tissue for light micro-
scope analysis. Resolution of structural detail is
limited only by the microscope and notby the tissue
October 1978 97preservation. Artefacts are minimal and minute
pathological changes are therefore readily detecta-
ble. The gain in sensitivity over conventional his-
tological techniques is enormous, making possible a
precise description of the type and character of
structural damage. Other major advantages are that
the perfusion process optimally fixes all organs for
sensitive light microscope assay and that the same
tissues are immediately available for electron mi-
croscope examination, should this be necessary.
These technical considerations are important forthe
establishment ofnormative data on the structure of
the nervous system. The advent ofthe new fixation
methods, coupled with the introduction ofthe elec-
tron microscope, has made possible a precise de-
FIGURE 1. Normal rat tibial nerve fixed by systemic perfusion
withglutaraldehyde and post-fixed in osmium tetroxide; IA.m
epoxy cross-section stained with toluidine blue. x 87.
FIGURE 2. PNS myelinated nerve fibers in a lumbar ventral root.
Fibers of varying sizes are composed of an axon (a) sur-
rounded by a darkly-staining myelin sheath. Note the central
capillary which has been cleared of blood cells by the sys-
temic perfusion with glutaraldehyde. Arrow points to
Schwann cell. x 980.6.
scription of the cellular elements of the central
(CNS) and the peripheral nervous system (PNS) (3).
The basic plan is common to both tissues. CNS
nerve cells or neurons possess elongate axonal pro-
cesses which communicate with the dendrites of
other nerve cells via terminal axonal synapses. In
the PNS, the axons ofdorsal root neurons situated
in spinal ganglia innervate sensory receptors, and
motor neurons located in the spinal cord supply
muscle fibers. The axon of nerve fibers is en-
sheathed by a chain ofcells, the oligodendrocyte in
the brain and spinal cord, and the Schwann cell in
peripheral nerves (Figs. 1 and 2). In many fibers,
this ensheathment takes the form of a multilayered
membranous structure known as myelin, the mem-
branes ofmyelin being continuous with those ofthe
ensheathing cell. Thejunctions between each length
ofmyelin sheath occur at regularly spaced intervals
along the length of the nerve fiber. Here, at the
nodes ofRanvier, the axon is attenuated and naked.
Other components of the nervous system include
astrocytes in the CNS and fibroblasts and collagen
in the PNS. Blood vessels of varying sizes also
permeate the brain, spinal cord and peripheral ner-
vous system.
Classifying Neurotoxic Injuries
The statement that a compound is neurotoxic
provides no information on the nature of its toxic
Table 1. Selected list of toxic chemicals producing structural
damage to the nervous system.
Chemical Response
Adriamycin Neuronopathy
Aluminum (fibrillar change)
Methylmercury
Vincristine (fibrillar change)
Acrylamide Axonopathy
Alkyl and aryl phosphates
Arsenic
p-Bromophenylacetyl urea
Carbon disulfide
Clioquinol (CNS only)
Diethyldithiocarbamiate
n-Hexane
Nitrofurans
Methyl n-butyl ketone
Polychlorinated biphenyls?
Sodium cyanate?
Thalidomide?
Thallium
Zinc pyrithione
Acetyl ethyl tetramethyl tetralin Myelinopathy
Alkyltin
Cuprizone
Hexachlorophene
Lead?
Tellurium
Lead? Neurovasculopathy
Environmental Health Perspectivesaction on the nervous system. If the neurotoxic
compound produces structural change, then the
pathology will have a specific character. Some
examples of these changes are breakdown of the
neuron (neuronopathy), axon (axonopathy), en-
sheathing cell and myelin sheath (myelinopathy), or
the vasculature (neurovasculopathy) (Table 1).
Considerable effort is presently being directed to-
wards the determination ofthe primary site oftissue
damage. This information will be ofuse in develop-
ing more sensitive methods to assay for neurotoxic-
ity and also provide alocus to study the biochemical
abnormality generally believed to precede and pre-
cipitate pathology (4). It is also well established that
primary structural changes in the nervous system
may precipitate secondary and tertiary effects. For
example, primary degeneration ofthe axon will also
cause a secondary degeneration of the myelin
sheath. This is the basis for the loss of myelin that
accompanies distal axonopathies.
Distal Axonopathy
A common, clinically expressed response of the
nervous system to chronic systemic intoxication
with a neurotoxic drug or chemical is the develop-
ment of peripheral neuropathy (5). This is man-
ifested in a laboratory animal by the gradual ap-
pearance ofsymmetrical hindlimb weakness, ataxia
and other gait disturbances such as a broad-based
hindlimb locomotion. As intoxication continues, the
lowerextremities become progressively weakerand
the animal loses weight. Eventually, the forelimbs
become weakened and the animal is rendered quad-
riplegic. The animal can be maintained in this de-
bilitated condition for some time, but continued
weight loss, inadequate nutrition, and nervous sys-
tem dysfunction eventually result in death. How-
ever, if the neurotoxin is removed, in time the ani-
mal will slowly recover, regain strength over a
period of many months, and eventually be able to
conduct the full spectrum ofbody movements. Re-
covery is never complete, however, because ir-
reversible changes in the central nervous system
may leave some residual spasticity and ataxia which
only appear when the peripheral nervous system
has regenerated and muscle strength has been re-
gained (6).
The neuropathology underlying these toxic
neuropathies has been studied in detail for some
compounds, notably acrylamide, tri-o-cresyl phos-
phate, n-hexane and methyl n-butyl ketone. It has
been demonstrated both by light and electron mi-
croscopy that these neurotoxins first affect the dis-
tal parts of axons located in the central and
peripheral nervous systems(7). The choice ofaxons
which are damaged seems to be related to the
diameter and length of the axon, long and large
axons initially undergoing distal axonal degenera-
tion and, subsequently, progressively shorter and
small axons degenerating in a similar manner. This
type ofpathology is known as distal axonopathy (8).
Another feature ofthese diseases is that the axonal
degeneration spreads towards the nerve cell body
with time, and continued intoxication. This
characteristic pattern has led to the use of the term
"dying-back" in connection with these neu-
ropathies.
The distal (dying-back) axonopathies associated
with acrylamide and n-hexane intoxication have
been most thoroughly studied and represent
paradigms for other neurotoxic injuries ofthis type.
The most dramatic clinical features of these dis-
eases in man and in animals are attributable to
changes in the peripheral nerves (i.e., peripheral
neuropathy). However, recent experimental work
has demonstrated that vulnerable axons in both
peripheral and central nervous systems die back
contemporaneously. Thus, long ascending spinal
cord tracts projecting to the medulla oblongata and
the cerebellum, involved in sensory perception and
motor coordination, begin to die-back at the same
time as hindlimb nerve fibers. Descending spinal
cord tracts involved in motor control undergo simi-
lar changes. Shorter nerve tracts become involved
later as the disease develops. At this time, the
shorter PNS nerve fibers supplying the forelimb,
CNS optic nerve tracts responsible for conducting
visual information and tracts in the hypothalamus
also become damaged (9). Comparable pathological
changes are believed to be responsible for the clini-
cal picture ofneuropathy in man which may include
weakness of the lower limb and hands, stocking-
and-glove sensory loss, loss of limb reflexes, optic
nerve degeneration and changes in mentation.
Principles of Neurotoxicity
Testing
Several points require emphasis in designing
neurotoxicity tests for the detection of neurotoxic
diseases such as distal axonopathies. Firstly, it has
to be clearly understood that the nervous system
changes are a response to systemic intoxication ir-
respective ofthe route ofadministration ofthe toxic
compound. The causation of axonal damage is not
understood, but is generally assumed to result from
one or more discrete metabolic neuronal lesions
produced by the neurotoxic agent. Secondly, there
is an all-or-none response to a neurotoxic agent
which produces structural change. Once the appro-
October 1978 99priate species, level, and duration of intoxication
have been established, then 100% of animals will
display nervous system damage. Thus, in contrast
to carcinogenicity testing where large numbers of
animals must be used because response is variable,
relatively small numbers of animals may be confi-
dently used to assay for neurotoxicity. A third prin-
ciple underlying neurotoxicity testing is the need for
subacute or chronic testing protocols. This is very
significant, since some neurotoxic agents produce
entirely different and unrelated effects depending
on the dosage. For example, n-hexane produces a
pharmacological and reversible CNS narcosis in ro-
dents at levels of 30,000 ppm administered for 60
min (10). By contrast, only a few hundred parts per
million administered continuously over a period of
many weeks will precipitate a central-peripheral
distal axonopathy (6). Another example is provided.
by the o-cresyl phosphates (11). After acute dosing,
these compounds produce striking reversible
neuromuscular blockade because of their an-
ticholinesterase properties. However, the well
known delayed neurotoxic effect produced by these
compounds is entirely unrelated to inactivation of
this enzyme. In the delayed distal axonopathy
caused by cresyl phosphates, there are striking
changes in spinal cord tracts and degeneration of
peripheral nerves. Axonal degeneration is again the
primary event, and this eventually results in fiber
loss with the attendant removal of the myelin
sheath. In conventional histological preparations,
this late change appears as a loss of myelin. This
observation has given rise to the so-called "de-
myelination" assay for neurotoxicity in fowl,
widely used in testing laboratories and presently
being recommended by the U. S. Environmental
Protection Agency for the testing of pesticides for
neurotoxic properties. Not only is the name "de-
myelination" a misnomer (see Table 1), the his-
topathological procedure employed is not capable
of revealing the early primary axonal change. It
should be clear from the foregoing that such a test
for neurotoxicity is totally inadequate.
Sensitive techniques using the contemporary tis-
sue preparation methods described above have to
be developed. Care must be taken to sample appro-
priate areas of the nervous system because distal
axonopathies are diseases which move in space
with time. Since nerve fibers in spinal cord tracts
and peripheral nerves die back from their ex-
tremities over a period ofmany months, it would be
inappropriate to attempt to detect early changes by
sampling the top of the sciatic nerve and a slice of
the brain. Experience with experimental hexacar-
bon and acrylamide neuropathies has also illumi-
nated another important problem regarding the
choice of behavioral or morphological methods to
detect the earliest evidence of neurotoxicity. It is
quite clear from these studies that it is possible to
detect discrete pathology in the nerve fiber axon
before any change in locomotion appears (12).
Therefore, in the distal axonopathy group of
neurotoxic diseases, it seems evident that "state of
the art"' neuropathology presently provides the
simplest sensitive assay for neurotoxicity. The
same premise is likely to be true for diseases af-
fecting other nervous system tissues, for example,
the neuronopathies, the myelinopathies, and the
neurovasculopathies. By contrast, morphological
techniques will be quite useless for assessing the
neurotoxic properties of those compounds which
exert a purely pharmacological effect on the ner-
vous system.
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FIGURE 3. Gross dissection of the sciatic/tibial/plantar nerve
complex and some associated intrinsic hindfoot muscles of
the rat. The sciatic nerve (sc) branches into the sural (s),
peroneal (p) and tibial (t) branches. At the level of the pop-
liteal fossa, the tibial nerve gives a branch to the medial head
of the gastrocnemius (m), a branch to the lateral head of the
gastrocnemius (1) plantaris and soleus, and a cluster of
branches accompanying the posterior tibial blood vessel to
flexor hallucis longus, tibialis posterior and flexor digitorum
longus (v). Distally, the posterior tibial nerve (pt) branches
into lateral plantar (1p) and medial plantar (mp) nerves. The
medial plantar nerve supplies three digits and there are two
branches to the flexordigitorum brevis muscle (d). The lateral
plantar nerve supplies two digits and, in addition, supplies the
lumbrical muscle (x) with a delicate branch. The two arrows
indicate the approximate level ofthe section illustrated in Fig
4. Fixed in glutaraldehyde and osmium tetroxide, dehydrated
and embedded in epoxy resin. x2. Reproduced by permission
from Spencer and Schaumburg (14).
Environmental Health Perspectives 100Developing a New Test
for Neurotoxicity
Studies on the distal axonopathies produced by
chronic intoxication with hexacarbon compounds
or with acrylamide have revealed the vulnerability
of large and long nerve fibers in the CNS and PNS
(13, 14). Some ofthe largest, long PNS nerve fibers
are contained within tibial nerves and supply calf
musculature with motor and sensory innervation
(Fig. 3). In the rat and the cat, these nerves also
appear to be the first to develop signs of distal
axonal degeneration, changes commencing in these
fibers before they occur in the longer but smaller
nerve fibers supplying the hindfoot. The tibial nerve
at the knee, just proximal to the existing sensitive
branches, would therefore appear to be the op-
timum site to assay for distal axonopathy in the
PNS (Fig. 4). As in other fibers at later time points,
axons first undergo swelling proximal to nodes of
Ranvier because of an abnormal accumulation of
filaments within the axoplasm at this site. The focal
axonal swelling may displace myelin locally thereby
producing short lengths of secondary demye-
lination. Eventually, nerve fibers undergo distal
breakdown and form n chain ofmvelin ovoids. Such
FIGURE 4. Intact tibial nerve (center) trunk and degenerating branches (right and left) to the calfmusculature. This and Figures 5 and 6
are from a rat with hexacarbon neuropathy. x 120.
FIGURE 5. Single, teased nerve fiber showing focal swellings in the axon. n denotes node ofRanvier. x170.
FIGURE 6. Single teased nerve fiber displaying a chain ofmyelin ovoids after undergoing complete degeneration. x140.
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tological sections but in nerve fibers which have
been prepared by the modem methods described
above and teased apart in liquid epoxy resin (2)
(Figs. 5 and 6).
Teased nerve fibers also display vividly other
types of specific pathology such as primary de-
myelination in myelinopathies, the rapid fiber de-
generation which accompanies dorsal root ganglion
neuronopathies and the demyelination accom-
panying neurovasculopathies. In the CNS, the
caudal medulla oblongata is a useful locus to detect
structural changes in neurotoxicities. In the distal
axonopathies, the pathology seen in sections is al-
ways symmetrical and restricted to the gracile tracts
located medially on the dorsal surface, the more
laterally placed cuneate tracts being spared until
late in the disease process (Fig. 7). The explanation
for this phenomenon lies in the fact that long axons
projecting from lumbar dorsal root neurons synapse
in the gracile nucleus of the medulla oblongata.
Since axons undergo distal degeneration in distal
axonopathies, the spectrum of change seen in the
PNS is concurrently taking place at the end of the
gracile tract in the CNS. The cuneate tracts also
project to the medulla oblongata, but because the
fibers originate from cervical dorsal root neurons,
axons are shorter, less vulnerable, and therefore
commence degeneration later in the disease pro-
cess.
Sampling the medulla oblongata also reveals the
early changes in dorsal root neuronopathies and in
myelinopathies. In these neuronopathies, all sen-
sory neurons in dorsal root ganglia degenerate con-
temporaneously and, as a secondary effect, there is
a rapid disintegration of the entire length of nerve
fiber. In this situation, therefore, the gracile and
cuneate tracts are equally affected at any one time
(Fig. 8). In myelinopathies, primary demyelination
would be scattered across the section ofthe medulla
oblongata and not limited to any one nerve fiber
tract.
The greatest caution must be taken in any mor-
phological assay to exclude tissue changes unas-
sociated with neurotoxicity. These may be caused
by poor fixation, trauma, or advancing age. The
recommended techniques for tissue preparation are
satisfactory if the use of systemic perfusion is
FIGURE 7. Medulla oblongata ofa rat with hexacarbon distal axonopathy showing selective degeneration ofthe gracile tracts (center).
x200.
Environmental Health Perspectives 102FIGURE 8. Medulla oblongata ofa rat with adriamycin dorsal root neuronopathy showing degeneration ofgracile (center) and cuneate
(sides) tracts. x2OG.
adopted. Immersion in glutaraldehyde is not a
satisfactory substitute, since tissue penetration is
poor, especially in the CNS, and the act of cutting
PNS nerves can itselfproduce spectacular artefacts
similar to real pathology (2, 15). Trauma to exposed
areas of plantar nerves is a natural consequence of
locomotion in rodents and perhaps in other species
(16). This is especially significant when the animal
lives on floors constructed ofwire mesh, the degree
of damage increasing with time spent in the cage
(14). Although animals caged on smooth floors for
months or years also display some fiber damage at
sites of vulnerability, the combination of smooth
floors and young animals will serve to avoid this
artefact. Using young adult animals also avoids the
naturally occurring age changes which develop in
the gracile tract of the medulla oblongata gradually
over the animal's lifetime. These changes appear as
axonal swelwings distinguishable in the light mi-
croscope from the swellings of hexacarbon
neuropathy only by the presence of narrow clefts
within the axoplasm in the aged animals (17) (Figs. 9
and 10).
In summary, therefore, by sampling two specific
areas of the CNS and PNS, the tibial nerve at the
knee and the medulla oblongata, it may be possible
to recognize the early signs of change in three en-
tirely different classes of neurotoxicity associated
with structural damage. However, before such a
new assay forneurotoxicity is recommended foruse
by the regulatory agencies, much additional work
with other neurotoxins has to be conducted.
Neurotoxicity, Human Disease,
and the Aging Process
There are remarkable similarities between the
pathological and clinical expressions of the toxic
distal axonopathies and the naturally occurring
neuropathies associated with diabetes, uremia, vi-
tamin deficiency, old age, and certain genetic-
metabolic diseases of unknown causation (8, 18).
Recognition of neurotoxic mimicry of human
neurological diseases places new emphasis on the
importance of understanding the susceptibility of
the nervous system to neurotoxic damage. Because
mimicry exists, it is entirely possible that chronic
exposure to neurotoxins will render man more sus-
ceptible to, or accelerate the onset of, the naturally
October 1978 103FIGURE 9. Giant axonal swellings (a) in the gracile tract of a rat with early hexacarbon distal axonopathy. x460.
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FIGURE 10. Axonal swellings (a) in an aged rat. Note the characteristic clefts (arrow) present within one axon. x500.
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neuronal reserve associated with aging. In estab-
lishing levels of exposure to any one neurotoxin, it
will also be important to be aware of the existence
of other neurotoxic substances producing the same
effect or alterating the potency of the first com-
pound. Such neurotoxic agents would be expected
to produce additive, or even potentiating or syner-
gistic effects. On the other hand, it will also be use-
ful to employ selected neurotoxins as tools to de-
velop animal models of those human diseases that
they mimic for the purposes ofdetermining etiology
and identifying prevention or cure.
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